Health

World Psoriasis Day 2023: Access for All

Every year on World Psoriasis Day, October 29th, the international psoriatic disease community unites to raise awareness and fight for progress. The theme of 2023, “Access for All,” underscores the vital need for Universal Health Coverage (UHC) to ensure that everyone, regardless of their location, income, or health condition, can access essential health services. This […]

thaipr.net

26 ต.ค. 66

ESAOTE’s new S-scan Open redefines excellence in magnetic resonance imaging

Esaote, a leading Italian company in ultrasound, dedicated MRI and healthcare IT, presents S-scan Open, the new configuration of S-scan, one of its best-selling MRI systems. S-scan Open is the result of constant commitment to research and development and of carefully listening to market needs and user feedback from all over the world. Introducing an updated version of its best-selling MRI […]

thaipr.net

26 ต.ค. 66

Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development

Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards in Barcelona, Spain. The annual award is presented to a company that demonstrates innovation in technologies, products, processes and services for the development […]

thaipr.net

25 ต.ค. 66

Global Healthcare Accreditation Welcomes Karin Jay as President of Global Strategy and Announces Renée-Marie Stephano’s Transition to CEO

New Leadership Aims to Reinforce GHA’s Position as the Foremost Authority in Medical and Well-being Travel Accreditation Global Healthcare Accreditation (GHA), the esteemed authority in accreditation and certification with a specialized focus in medical and wellness travel, has named Karin Jay as its new President of Global Strategy. This appointment coincides with the official transition of Renée-Marie Stephano from […]

thaipr.net

24 ต.ค. 66

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study

Currax Pharmaceuticals LLC (“Currax”) today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compared CONTRAVE®/MYSIMBA® to a similar product for the purpose of measuring major adverse cardiovascular events (MACE). The primary analysis included over 24,600 patients with an average…

thaipr.net

19 ต.ค. 66
1 … 29 30 31 32 33 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.